TrialJAMA ophthalmology2021

Choice of Dose Level for a Randomized Clinical Trial of Low-Dose Bevacizumab vs Laser for Type 1 Retinopathy of Prematurity.

Raymond T Kraker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.